Research Article
[Retracted] Diagnostic Value of FTO Combined with CEA or CYFRA21-1 in Nonsmall Cell Lung Cancer
Table 2
Association of CEA with clinical data of NSCLC patients (n, %).
| | Index | Relative expression of CEA | value | | High expression (n = 30) | Low expression (n = 30) |
| | Age | | ≥60 years (n = 33) | 15 | 18 | 0.436 | | <60 years (n = 27) | 15 | 12 | | Gender | | Male (n = 35) | 16 | 19 | 0.432 | | Female (n = 25) | 14 | 11 | | Tumour size | | ≥3 cm (n = 30) | 18 | 12 | 0.121 | | <3 cm (n = 30) | 12 | 18 | | Clinical staging | | I + II (n = 37) | 14 | 23 | | | III + IV (n = 23) | 16 | 7 | | Lymph node metastasis | | Yes (n = 18) | 10 | 8 | 0.573 | | None (n = 42) | 20 | 22 | | Tumour type | | Squamous cell carcinoma (n = 27) | 8 | 19 | | | Adenocarcinoma (n = 33) | 22 | 11 |
|
|
Note. denotes a notable difference. |